協和キリンの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2013/10/08 | 990 | 1,002 | 985 | 999 | +7 | +0.7% | 1,199,000 |
| 2013/10/07 | 1,006 | 1,007 | 991 | 992 | -9 | -0.9% | 959,000 |
| 2013/10/04 | 999 | 1,013 | 995 | 1,001 | +1 | +0.1% | 975,000 |
| 2013/10/03 | 1,002 | 1,011 | 999 | 1,000 | -1 | -0.1% | 1,098,000 |
| 2013/10/02 | 1,007 | 1,008 | 997 | 1,001 | -7 | -0.7% | 1,858,000 |
| 2013/10/01 | 1,010 | 1,019 | 1,006 | 1,008 | ±0 | ±0% | 644,000 |
| 2013/09/30 | 1,015 | 1,015 | 1,000 | 1,008 | -7 | -0.7% | 851,000 |
| 2013/09/27 | 1,024 | 1,028 | 1,011 | 1,015 | -9 | -0.9% | 798,000 |
| 2013/09/26 | 1,012 | 1,024 | 996 | 1,024 | +12 | +1.2% | 881,000 |
| 2013/09/25 | 1,028 | 1,028 | 1,011 | 1,012 | -3 | -0.3% | 904,000 |
| 2013/09/24 | 1,008 | 1,019 | 1,007 | 1,015 | -3 | -0.3% | 752,000 |
| 2013/09/20 | 1,012 | 1,019 | 1,010 | 1,018 | +12 | +1.2% | 1,058,000 |
| 2013/09/19 | 1,004 | 1,007 | 997 | 1,006 | +7 | +0.7% | 1,154,000 |
| 2013/09/18 | 1,002 | 1,005 | 993 | 999 | +8 | +0.8% | 1,045,000 |
| 2013/09/17 | 1,004 | 1,005 | 990 | 991 | -3 | -0.3% | 791,000 |
| 2013/09/13 | 1,004 | 1,004 | 980 | 994 | -16 | -1.6% | 2,952,000 |
| 2013/09/12 | 1,012 | 1,012 | 1,003 | 1,010 | +4 | +0.4% | 1,124,000 |
| 2013/09/11 | 1,017 | 1,024 | 1,003 | 1,006 | -3 | -0.3% | 1,403,000 |
| 2013/09/10 | 1,008 | 1,014 | 999 | 1,009 | -16 | -1.6% | 1,801,000 |
| 2013/09/09 | 1,020 | 1,027 | 1,012 | 1,025 | +32 | +3.2% | 998,000 |
| 2013/09/06 | 1,013 | 1,013 | 990 | 993 | -21 | -2.1% | 1,152,000 |
| 2013/09/05 | 1,019 | 1,021 | 1,005 | 1,014 | -8 | -0.8% | 875,000 |
| 2013/09/04 | 1,015 | 1,028 | 1,014 | 1,022 | -8 | -0.8% | 1,299,000 |
| 2013/09/03 | 1,017 | 1,036 | 1,017 | 1,030 | +13 | +1.3% | 1,090,000 |
| 2013/09/02 | 1,002 | 1,022 | 999 | 1,017 | +24 | +2.4% | 1,159,000 |
| 2013/08/30 | 1,011 | 1,017 | 992 | 993 | -17 | -1.7% | 1,460,000 |
| 2013/08/29 | 1,016 | 1,020 | 1,004 | 1,010 | -6 | -0.6% | 903,000 |
| 2013/08/28 | 999 | 1,022 | 987 | 1,016 | +11 | +1.1% | 1,537,000 |
| 2013/08/27 | 1,010 | 1,017 | 1,001 | 1,005 | -21 | -2% | 1,407,000 |
| 2013/08/26 | 1,041 | 1,041 | 1,024 | 1,026 | -4 | -0.4% | 1,049,000 |
| 2013/08/23 | 1,037 | 1,037 | 1,022 | 1,030 | +7 | +0.7% | 1,849,000 |
| 2013/08/22 | 1,016 | 1,032 | 1,014 | 1,023 | ±0 | ±0% | 1,192,000 |
| 2013/08/21 | 1,028 | 1,030 | 1,015 | 1,023 | -1 | -0.1% | 1,112,000 |
| 2013/08/20 | 1,045 | 1,049 | 1,023 | 1,024 | -28 | -2.7% | 1,185,000 |
| 2013/08/19 | 1,052 | 1,059 | 1,044 | 1,052 | +1 | +0.1% | 766,000 |
| 2013/08/16 | 1,057 | 1,065 | 1,033 | 1,051 | -6 | -0.6% | 1,452,000 |
| 2013/08/15 | 1,064 | 1,065 | 1,051 | 1,057 | -8 | -0.8% | 1,680,000 |
| 2013/08/14 | 1,049 | 1,065 | 1,043 | 1,065 | +20 | +1.9% | 1,522,000 |
| 2013/08/13 | 1,015 | 1,046 | 1,015 | 1,045 | +38 | +3.8% | 1,305,000 |
| 2013/08/12 | 1,004 | 1,024 | 997 | 1,007 | -7 | -0.7% | 2,233,000 |
| 2013/08/09 | 1,013 | 1,023 | 1,000 | 1,014 | +13 | +1.3% | 1,651,000 |
| 2013/08/08 | 1,000 | 1,029 | 997 | 1,001 | -6 | -0.6% | 1,306,000 |
| 2013/08/07 | 1,020 | 1,033 | 1,007 | 1,007 | -33 | -3.2% | 1,626,000 |
| 2013/08/06 | 1,034 | 1,041 | 1,014 | 1,040 | +4 | +0.4% | 1,247,000 |
| 2013/08/05 | 1,035 | 1,049 | 1,021 | 1,036 | -2 | -0.2% | 1,030,000 |
| 2013/08/02 | 1,013 | 1,039 | 1,008 | 1,038 | +38 | +3.8% | 1,389,000 |
| 2013/08/01 | 985 | 1,002 | 979 | 1,000 | +22 | +2.2% | 1,835,000 |
| 2013/07/31 | 1,000 | 1,003 | 976 | 978 | -39 | -3.8% | 2,845,000 |
| 2013/07/30 | 1,018 | 1,024 | 1,005 | 1,017 | -18 | -1.7% | 2,269,000 |
| 2013/07/29 | 1,062 | 1,064 | 1,033 | 1,035 | -50 | -4.6% | 1,576,000 |
2901～
2950
件表示中 / 3767件
類似銘柄と比較する
現在ご覧いただいている「協和キリン」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 協和キリン | 264,200円 | -3.5% | -11.3% | 2.27% | 24.27倍 | 1.65倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
| アステラス薬 | 168,900円 | +0.9% | +380.2% | 4.62% | 23.27倍 | 2.00倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
| 塩野義 | 258,500円 | +20.9% | +10.6% | 2.55% | 12.22倍 | 1.61倍 |
|
抗ＨＩＶ薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
| エーザイ | 464,200円 | +0.1% | -3.4% | 3.45% | 31.56倍 | 1.55倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
| 小野薬 | 165,700円 | +0.6% | +43.3% | 4.83% | 11.62倍 | 1.00倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
市場注目の銘柄
チャート関連のコラム
